ahlam1399
08-29-2016, 06:12 PM
BRIEF-Amgen an**unces positive top-line results from phase 3 study
* Amgen an**unces positive top-line results from phase 3study of prolia (de**sumab) in patients receiving glucocorticoidtherapyhttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=IbFdfQC-wVc:4YuW_x1VML0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IbFdfQC-wVc:4YuW_x1VML0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=IbFdfQC-wVc:4YuW_x1VML0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IbFdfQC-wVc:4YuW_x1VML0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=IbFdfQC-wVc:4YuW_x1VML0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/IbFdfQC-wVc
* Amgen an**unces positive top-line results from phase 3study of prolia (de**sumab) in patients receiving glucocorticoidtherapyhttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=IbFdfQC-wVc:4YuW_x1VML0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IbFdfQC-wVc:4YuW_x1VML0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=IbFdfQC-wVc:4YuW_x1VML0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IbFdfQC-wVc:4YuW_x1VML0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=IbFdfQC-wVc:4YuW_x1VML0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/IbFdfQC-wVc